wy 48252 has been researched along with cysteine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bender, RH; Carlson, RP; Chang, J; Hand, JM; Kreft, AF; Kubrak, DM; Musser, JH | 1 |
| Auen, MA; Chang, J; Hand, JM; Kreft, AF; Musser, JH; Schwalm, SF | 1 |
2 other study(ies) available for wy 48252 and cysteine
| Article | Year |
|---|---|
N-[(arylmethoxy)phenyl] and N-[(arylmethoxy)naphthyl] sulfonamides: potent orally active leukotriene D4 antagonists of novel structure.
Topics: Acetophenones; Animals; Bronchi; Chemical Phenomena; Chemistry; Constriction, Pathologic; Cyclooxygenase Inhibitors; Cysteine; Edema; Guinea Pigs; Hydroxyquinolines; Indomethacin; Inflammation; Lipoxygenase Inhibitors; Molecular Structure; Muscle Contraction; Naphthalenes; SRS-A; Structure-Activity Relationship; Sulfonamides; Tetrazoles; Trachea | 1989 |
Wy-48,252 (1,1,1-trifluoro-N-[3-(2-quinolinylmethoxy)phenyl]methane sulfonamide) an orally active leukotriene D4 antagonist: pharmacological characterization in vitro and in vivo in the guinea pig.
Topics: Animals; Bronchi; Capillary Permeability; Cysteine; Guinea Pigs; Histamine; Hydroxyquinolines; In Vitro Techniques; Indomethacin; Male; Muscle Contraction; Muscle, Smooth; Ovalbumin; SRS-A; Trachea | 1989 |